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Abstract
Background: The purpose of this study was to quantify the contribution of comorbidity to activity limitations in
populations with chronic cardiovascular disease, diabetes or respiratory disease (index conditions), with emphasis
on musculoskeletal comorbidity (arthritis or back problems).
Methods: Analysis of the 2005 Canadian Community Health Survey 3.1 (age 20+ years, n = 115,915). Prevalence
ratios for activity limitations in people with the index conditions and co-occurring musculoskeletal disease, adjusted
for age, gender, and socioeconomic factors, were used to estimate population associated fractions (PAF).
Results: Comorbid arthritis and back problems significantly increased the risk of activity limitations across all index
conditions with prevalence ratios of 1.60 and 1.46 for cardiovascular disease, 1.51 and 1.36 for diabetes, and 1.38
and 1.44 for respiratory disease for arthritis and back problems respectively. Arthritis and back problems accounted
for at least 13% and 9% of activity limitations in the index populations.
Conclusions: While chronic musculoskeletal conditions are not always considered priorities in chronic disease
prevention, they account for a substantial proportion of activity restrictions seen in people with cardiovascular
disease, diabetes and respiratory disease, with implications for prevention and control strategies.
Background
People are living longer with chronic diseases and
sedentary lifestyles and an abundance of high calorie
food put people at further risk of a range of chronic
conditions including heart disease, diabetes and arthritis
[1,2]. The increasing burden of chronic diseases on cur-
r e n ta n df u t u r eu s eo ft h eh e a l t hc a r es y s t e mi ni n d u s -
trialized countries is driving the adoption of chronic
disease prevention and control strategies. A component
of these strategies is helping individuals acquire the
skills to manage their health and maintain an active life.
A frequent focus of attention for chronic disease pre-
vention and management programs has been on cancer,
coronary heart disease, diabetes, and chronic respiratory
disease with many programs focusing on a single disease
[3]. However, many people have comorbidities (i.e. mul-
tiply co-occurring diseases) [4]. The occurrence of
comorbidity influences decisions in many areas of health
including prevention, complexity of treatment and ser-
vice utilization, as well as influencing outcomes such as
limitations in activity, participation restriction and mor-
tality [5,6]. In spite of this, little attention has been paid
to comorbidity and the effect that comorbid conditions
have on limitations in activity and hence on one’s ability
to engage in self management behaviours, in particular
physical activity[7,8].
Thus, the goal of this study is to quantify the contribu-
tion of comorbidity to activity limitations in people with
existing chronic cardiovascular disease, diabetes or
respiratory disease, with particular emphasis on muscu-
loskeletal comorbidity, specifically arthritis and back pro-
blems, as these conditions are a frequent comorbidity
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any medium, provided the original work is properly cited.[9,10] and the most frequent cause of activity limitations
in the population [11,12]. Cancer was not included due
to its low reported prevalence.
Methods
Data were obtained from the 2005 Canadian Commu-
nity Health Survey (CCHS, Cycle 3.1), a comprehensive
cross-sectional survey of health status and determinants
administered by Statistics Canada, Canada’s central sta-
tistical agency. The target population included indivi-
duals 12 years of age and older living in private
dwellings excluding individuals living on Indian Reserves
or in certain remote areas, institutional residents and
members of the Armed Forces. The survey covered
approximately 98% of the Canadian population aged 12
and older.
A two-stage cluster design was employed to arrive at a
representative sample of the household population. In
the first stage, homogeneous strata were formed and
independent samples of clusters were drawn from each
stratum. In the second stage, dwelling lists were pre-
pared for each cluster and dwellings, or households,
were selected from the lists.
More specifically, each of the 10 provinces was divided
into three types of regions: major urban centres, cities,
and rural regions. Geographic or socio-economic strata
were created within each major urban centre. Within
the strata, dwellings were regrouped to create clusters.
In each stratum, six clusters were chosen by a random
sampling method with a probability proportional to size,
the size of which corresponded to the number of house-
holds. The other cities and rural regions of each province
were stratified first on a geographical basis, then accord-
ing to socio-economic characteristics. Once the new clus-
ters were listed, the sample was obtained using a
systematic sampling of dwellings. Further details of sur-
vey methodology, including strategies to ensure represen-
tativeness of the sample, have been published [13].
The questionnaire was administered using computer-
assisted personal interviews (83% of the sample) and tel-
ephone interviews. With 132,221 participants, household
and person response rates were high (84.9% and 92.9%
respectively). For this study, analyses are focused on the
adult population aged 20+ years (n = 115,915). The data
used in this study were publicly available.
The presence of chronic conditions was determined
using the lead-in statement: “We are interested in long-
term conditions that have lasted or are expected to last
six months or longer and that have been diagnosed by a
health professional. Do you have...”. Of the 27 specific
self-reported chronic conditions that are collected by
the CCHS, this study considered the following chronic
conditions: cardiovascular conditions (indentified as the
self-reported presence of “high blood pressure”, “heart
disease” or “suffer from the effects of a stroke”), “dia-
betes”, respiratory conditions (identified as the self-
reported presence of “asthma”, “chronic bronchitis”,
“chronic obstructive pulmonary disease” or “emphy-
sema”), “arthritis or rheumatism, excluding fibromyalgia”
(referred to as arthritis), and “back problems, excluding
fibromyalgia and arthritis” (referred to as back pro-
blems). All other chronic conditions were grouped
together.
The health outcome of interest for this study was a
global measure of activity limitation.
Prefaced with “The next few questions deal with any
current limitations in your daily activities caused by a
long-term health condition or problem,” respondents
were asked, “Do you have any difficulty...walking, climb-
ing stairs, bending, learning or doing any similar activ-
ities?” and “Does a long-term physical condition or
mental condition or health problem, reduce the amount
or the kind of activity you can do...at home?...at
school?...at work?...in other activities, for example, trans-
portation or leisure?” For each of these, respondents
indicated either “sometimes”, “often”, “never.” Respon-
dents were categorised as having an activity limitation if
they responded as sometimes or often having any
difficulty.
Age was grouped in 10 year intervals commencing at
20-29 to age 80+. Age over 80 years could not be
further broken down as it was available in grouped for-
mat only. Race was categorised as white or visible min-
ority. The Asian population is the largest visible
minority group in Canada; only a small proportion of
the population identified themselves as black or Latin
American (1.7% and 0.7%, respectively). The highest
level of education was dichotomized as more than high
school or high school or less. Total household income
was grouped as >$15,000, $15,000-$29,999, $30,000-
$49,999, $50,000-%79,000, and >$80,000. Body Mass
Index (BMI = weight [kg]/height [meters]
2) was calcu-
lated using participant-reported height and weight,
excluding pregnant women. BMI was considered as:
underweight, (<18.5 kg/m
2)n o r m a lw e i g h t( 1 8 . 5 - < 2 4 . 9
kg/m
2), and overweight/obese (≥25 kg/m
2).
Statistical Analyses
Data weights, provided by Statistics Canada to account
for sample design, non-response and post-stratification,
were used to provide estimates representative of the
household population aged 20+ years. The methods
employed by Statistics Canada to calculate weights have
been published [13]. Variances were calculated using
rescaled weights and incorporated design factors pro-
vided by Statistics Canada.
Descriptive analyses examined the distribution of
demographic and socioeconomic characteristics and
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reporting cardiovascular conditions, diabetes and
respiratory conditions (the index conditions). Addition-
ally, the prevalence of index and comorbid conditions,
proportion with activity limitation, prevalence of comor-
bid conditions among the index groups, and proportion
with activity limitations among pair of index and comor-
bid conditions were examined.
Three sets of analyses were carried out for populations
defined by the presence of one of the specific chronic
conditions of interest: cardiovascular conditions, dia-
betes or respiratory disease (index conditions). Following
the methodology used in Perruccio et al,[14] adjusted
prevalence ratios (PRs) for activity limitation were esti-
mated through multivariate log-Poisson regression ana-
lyses with robust variance estimation [15,16]. The log-
Poisson regression included age, gender education,
income, race, BMI, and chronic conditions as indicated
above. Population-associated fractions (PAF) for activity
limitations were calculated for each pair of index and
comorbid conditions. SAS 9.1 was used for all statistical
analyses.
Results
Table 1 contrasts the demographic and socioeconomic
characteristics and BMI levels of the overall population
and the groups characterized by the index conditions.
The index condition groups generally were comprised of
a greater proportion of older individuals; this likely par-
tially explains some of the differences in education and
income levels within these groups relative to the overall
population. Nearly 51% of the overall population was
overweight/obese. This is in contrast to the 74% and
67% within the diabetes and cardiovascular sub-groups,
respectively.
Sixty-nine percent of respondents over 20 years of age
reported at least one chronic condition with 43% report-
ing at least one co-occurring (comorbid) condition. The
prevalence of the chronic conditions and the proportion
with activity limitations are presented in Table 2, along
with the proportion of the population reporting pairs of
index conditions with another condition and the propor-
tion of these reporting activity limitation. Apart from the
combination of cardiovascular disease with comorbid
diabetes reported by 60.2%, arthritis was consistently
among the most commonly reported comorbid condi-
tion, being reported by a third of people with the index
conditions. The proportion of comorbid back problems
was only slightly lower. Approximately half of all indivi-
duals with the index conditions reported activity limita-
tion, the proportion being markedly higher for those with
co-morbidity, particularly arthritis and back problems.
Table 3 presents the association between the comor-
bid condition and the prevalence of activity limitations
presented as prevalence ratios adjusted for age, gender,
income, education, race, BMI and multimorbidity. Each
column in the tables corresponds to a population of
individuals with a certain index condition; the rows cor-
respond to the factors included in the regression. Gener-
ally, the risk of activity limitations within each index
condition increased with increasing age, with low
income and with above- or below-average weight.
Within cardiovascular disease, women (PR 0.93, 95% CI:
0.89, 0.97) and visible minorities (PR 0.85, 95% CI: 0.78,
0.93) had a lower risk of activity limitations; this associa-
tion was not significant in those with diabetes or
respiratory conditions. Education level was not signifi-
cantly associated with activity limitations across the
three index conditions. Comorbid arthritis significantly
increased the risk of activity limitations across all index
conditions, as did back problems, even after adjustment
for other covariates.
Prevalence ratios were used to calculate population-
associated fractions within each of the index condition
populations for pairs of comorbid conditions (Table 2).
For all three index conditions, PAFs were highest for
arthritis as a comorbid condition, followed by back
problems.
When arthritis and back problems were combined
(results not shown), the same pattern emerged; co-exist-
ing musculoskeletal conditions increased the risk of
activity limitation by at least 80%: PR 2.12, 95% CI: 2.00,
2.25 in those with cardiovascular disease; PR 1.81, 95%
CI 1.66, 1.96 in those with diabetes; PR 1.86, 95% CI
1.70, 2.03 in those with respiratory disease. Co-occurring
musculoskeletal disease accounted for roughly 30% of all
activity limitations in people with cardiovascular disease,
diabetes and respiratory disease.
Discussion
While research has examined the impact of chronic
conditions on an individual’s ability to perform daily
activities related to independent living,[12,17-20] this
study contributes to knowledge by estimating the contri-
bution of comorbid disease to increasing the risk of
activity limitations specific a l l yi np e o p l ew i t he x i s t i n g
cardiovascular disease, diabetes or respiratory disease.
We found that among people with cardiovascular dis-
ease, diabetes and respiratory disease, comorbid muscu-
loskeletal conditions (arthritis and back problems) both
increased the risk and accounted for a substantial pro-
portion of activity limitations. Comorbid cardiovascular
disease also contributed a substantial proportion to
activity limitations in those with diabetes.
The population associated fractions calculated in this
study for populations with specific chronic diseases are
generally higher that those found in an earlier study for
the total population which also used activity limitations
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from 3.7% to 7.5% for the contribution of diabetes and
individual cardiovascular and respiratory conditions to
activity limitations in the general population, adjusted
for a range of comorbidities. Corresponding values for
arthritis and back problems were 16.8% and 4.3%
respectively. Griffith et al. [21] reported relatively large
population attributable risks for functional disability
(examining independently activities of daily living and
instrumental activities of daily living) for pairs of
chronic conditions which included arthritis. They report
some of the highest values for the combination of
arthritis and heart problems. Their study was limited to
individuals aged 65 and over, however. These differences
suggest there are differential impacts for individuals with
specific medical conditions depending on the presence
of particular comorbidities, and the age structure of the
population under study. An important advantage of the
present study was the consideration of conditions of
high prevalence in the population or of considerable
public interest, or both, across the full adult age range.
The differential impacts we report may need to be taken
into account in setting priorities for public health
interventions.
Older age, lower income, and increased weight (over-
weight/obese) were found to be significantly associated
with activity limitations in people with cardiovascular
disease, diabetes and respiratory disease. This was
expected as these are common risk factors for these
chronic diseases[22,23] and for comorbidity[24] as well
as for activity limitations and disability in general
[25-27].
Arthritis, back problems, cardiovascular disease, dia-
betes and respiratory diseases can all interfere with phy-
sical functioning and activity levels[14,19,28]. For
example, those with arthritis are not as physically active
as persons without arthritis, likely partly attributable to
the pain, stiffness, and joint destruction associated with
the disease[29]. Studies in the US population have
shown that arthritis is a barrier to physical activity such
that individuals with eitherd i a b e t e so rh e a r td i s e a s e
who also have arthritis were more likely to be physically
Table 1 Population characteristics, overall and by index condition group
Overall
(n = 115,915)
(%)
Cardiovascular disease
(n = 29,281)
(%)
Diabetes
(n = 8,100)
(%)
Respiratory disease
(n = 13,206)
(%)
Age (years)
20-29 18.3 2.3 2.8 19.2
30-39 18.4 4.7 4.5 15.9
40-49 22.5 12.6 12.2 20.1
50-59 17.8 23.2 23.5 17.0
60-69 11.8 24.9 26.3 12.8
70-79 7.7 21.0 21.8 10.0
80+ 3.7 11.2 8.9 5.0
Gender
Male 49.0 48.6 53.9 41.0
Female 51.0 51.5 46.1 59.0
Race
White 83.8 87.7 85.6 88.2
Visible minority 16.2 12.3 14.5 11.8
Education
High school or less 32.5 45.9 47.9 36.1
More than high school 67.5 54.1 52.1 64.0
Income
<$15,000 5.8 9.2 11.1 8.9
$15,000-$29,999 13.1 21.1 24.8 17.6
$30,000-$49,999 20.2 23.3 23.5 19.8
$50,000-$79,999 27.0 23.6 23.4 23.3
>$80,000 33.9 22.8 17.2 30.4
BMI
Underweight 2.5 1.7 1.0 2.9
Normal weight 46.6 31.0 25.0 42.3
Overweight/obese 50.9 67.3 74.0 54.8
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[30,31]. Activity limitations can be thought of as a global
measure of disability and the general definition used in
the CCHS captures restrictions in numerous activities
including physical function (walking, climbing stairs,
etc) as well as activities at home, work, school, and lei-
sure. This definition reflects physical performance and
ability to carry out a range of activities[32] with implica-
tions for physical activity.
Our study is not without limitations as health surveys
based on self-reported data have obvious disadvantages.
The absence of clinician-assessed chronic conditions
may lead to inaccuracies in the prevalence of chronic
disease[33]. Nonetheless, such surveys are generally con-
sidered to be a reliable, economic, and practical means
for measuring morbidity[33-35]. Our measure of activity
limitations was a global measure and does not exclu-
sively address physical activity as such, although this is
included in the measure. As the cross-sectional nature
of the data prohibits us from drawing any causal infer-
ences, future work should build upon these findings and
assess the longitudinal relationship between comorbidity
and activity limitations. However, regardless of the tim-
ing of the development of the chronic conditions and
outcome, the implications of musculoskeletal comorbid-
ity on health outcomes are significant. Finally, we only
considered pairs of chronic conditions and their rela-
tionship with activity limitations. Approximately one
quarter of the study population reported having three or
more chronic conditions and the impact of this should
be investigated. Further work should also consider the
impact of mental health conditions on these associations
as psychological distress has been shown to add to the
negative impact of chronic conditions on limitations in
everyday activities[36-38].
Although numerous chronic disease prevention strate-
gies and practice guidelines have been developed, they
mainly address single chronic conditions and ignore the
presence of co-existing conditions. Our findings suggest
that the implementation of effective prevention, treat-
ment and management strategies for chronic disease
might be affected by musculoskeletal comorbidity. While
musculoskeletal conditions are not always considered to
be among the top priorities in chronic disease prevention,
they are the most prevalent chronic conditions. This
population-based study points to the importance of tak-
ing into account the impact of arthritis and back pro-
blems on activity limitations in persons with co-existing
cardiovascular disease, diabetes and respiratory disease
when designing intervention and prevention strategies.
There can be potential synergies and antagonisms in
populations with comorbid conditions and potential pro-
blems in delivering intervention and prevention strategies.
However, approaches which consider the presence and
impact of comorbid conditions are likely of greater benefit
to the population and patient than approaches which
overlook them. For example, physical activity is a key
prevention strategy particularly for the prevention of
Table 2 Prevalence of index and comorbid conditions, proportion with activity limitation, and population-associated
fractions
† (%) for activity limitation for index-comorbid condition pairs
Chronic conditions
Index
condition
CVD Diabetes Respiratory
disease
Arthritis/
rheumatism
Back
problems
Other chronic
conditions
Prevalence of condition (%) 20.1 5.5 12.2 18.5 20.5 15.7
Proportion with activity limitation (%) 51.4 53.3 49.8 63.8 57.3 22.0
Comorbid chronic conditions
Proportion who have comorbid condition (%) CVD - 16.5 14.3 38.3 26.9 19.4
Diabetes 60.2 - 15.3 39 25.6 8.1
Respiratory
disease
27.4 8.1 - 29.9 32.4 32.4
Proportion with index and comorbid condition
with activity limitation (%)
CVD - 60.7 68.9 71.3 70.4 39.3
Diabetes 60.7 - 69.5 72.7 73.6 36.5
Respiratory
disease
68.9 69.5 - 75.3 68 30.9
Population Associated Fraction
† (%) CVD - 2.6 3.8 19.8 11.6 2.5
Diabetes 13.4 - 2.9 17.8 9.4 0.8
Respiratory
disease
3.1 0 - 12.5 13.4 0
† adjusted for other comorbidities, age, gender, race, education, income and BMI.
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eral. When designing intervention strategies, it needs to be
recognized that comorbid arthritis and back problems is
not a contraindication, although modifications may need
to be made [39]. Further, regular physical activity has been
shown to be beneficial in managing symptoms associated
with arthritis and back problems[40].
Conclusion
The adoption of chronic disease prevention and control
strategies is becoming more critical as the burden of
chronic diseases in industrialized countries continues to
increase. A component of these strategies encourages
individuals to manage their health and maintain an active
life. To date, many of these strategies have focused on
single diseases. Less attention has been paid to comorbid-
ity and the effect that comorbid conditions have on activ-
ity and consequently on one’s ability to engage in self-
management practices, in particular physical activity.
Among people with cardiovascular disease, diabetes and
respiratory disease, comorbid musculoskeletal conditions
both increased the risk and accounted for a substantial
proportion of activity limitations. This suggests the imple-
mentation of effective prevention, treatment and manage-
ment strategies for these chronic diseases might be
affected by musculoskeletal comorbidity. While musculos-
keletal conditions are not always considered to be among
the top priorities in chronic disease prevention, they are
the most prevalent chronic conditions. Musculoskeletal
conditions and comorbidity need to be accounted for
when designing intervention and prevention strategies.
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Table 3 Prevalence ratios (95% CI) for activity limitation from log-Poisson regression analyses by index condition
Cardiovascular disease
(n = 29,281)
Diabetes
(n = 8,100)
Respiratory disease
(n = 13,206)
Comorbid condition
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Race (ref: white)
Visible minority 0.85 (0.78 - 0.93) 0.88 (0.77 - 1.01) 0.94 (0.84 - 1.05)
Education (ref: more than high school)
High school or less 0.97 (0.93 - 1.01) 0.99 (0.92 - 1.05) 0.98 (0.93 - 1.04)
Income (ref: >$80,000)
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